Navigation Links
Promising news for solar fuels from Berkeley Lab researchers at JCAP
Date:3/7/2014

ossil fuels. However, realizing this artificial photosynthesis ideal will require a number of technological breakthroughs including high performance photocathodes that can catalyze fuel production from sunlight alone.

Last year, Moore and his research group at JCAP took an important step towards the photocathode goal with their gallium phosphide/cobaloxime hybrid. Gallium phosphide is an absorber of visible light, which enables it to produce significantly higher photocurrents than semiconductors that only absorb ultraviolet light. The cobaloxime catalyst is also Earth-abundant, meaning it is a relatively inexpensive replacement for the highly expensive precious metal catalysts, such as platinum, currently used in many solar-fuel generator prototypes.

"The novelty of our approach is the use of molecular catalytic components interfaced with visible-light absorbing semiconductors," Moore says. "This creates opportunities to use discrete three-dimensional environments for directly photoactivating the multi-electron and multi-proton chemistry associated with the production of hydrogen and other fuels."

The efficiency analysis performed by Moore and his colleagues also confirmed that the light-absorber component of their photocathode is a major bottleneck to obtaining higher current densities. Their results showed that of the total number of solar photons striking the hybrid-semiconductor surface, measured over the entire wavelength range of the solar spectrum (from 200 to 4,000 nanometers) only 1.5-percent gave rise to a photocurrent.

"This tells us that the use of light absorbers with improved spectral coverage of the sun is a good start to achieving further performance gains, but it is likely we will also have to develop faster and more efficient catalysts as well as new attachment chemistries. Our modular assembly method provides a viable strategy to testing promising combinations of new materials," Moore says.

"Efficienc
'/>"/>

Contact: Lynn Yarris
lcyarris@lbl.gov
510-486-5375
DOE/Lawrence Berkeley National Laboratory
Source:Eurekalert  

Page: 1 2 3

Related biology news :

1. First complete full genetic map of promising energy crop
2. Scripps Research Institute scientists find promising vaccine targets on hepatitis C virus
3. Promising developments in early diagnosis and treatment of mesothelioma
4. Ultrasensitive biosensor promising for medical diagnostics
5. UH Case Medical Center, CardioKinetix reveal promising data for treatment for heart failure
6. 22 of Americas most promising scientists selected as Pew Biomedical Scholars
7. American Health Assistance Foundation announces grants to advance promising vision research
8. Space research institute awards funding to promising medical products
9. Promising new drug target for inflammatory lung diseases
10. Berkeley Lab scientists help develop promising therapy for Huntingtons disease
11. Stem cells + nanofibers = Promising nerve research
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Promising news for solar fuels from Berkeley Lab researchers at JCAP
(Date:6/24/2015)... 2015 This report provides market analysis of ... years. It contains an analysis of the drivers, challenges, ... impact from the short, medium, and long term perspective ... market, and technology trends that currently, prevail in the ... authorities to efficiently manage the increasing marine traffic and ...
(Date:6/23/2015)... DUBLIN , June 22, 2015 ... has announced the addition of the "Body-Worn ... Share, Growth, Trends and Forecast 2014 - 2020" ... report offers strategic analysis of the global body-worn ... market has been segmented on the basis of ...
(Date:6/17/2015)... und GERMANTOWN, Maryland , June 17, ... ®   Produktlinie mit DNA-Tests verbessert den Analyseprozess ... QGEN ; Frankfurt Prime Standard: QIA) hat heute ... der Produktlinie Investigator ® ... eingeführt. Die neuen Kits zur Erstellung genetischer Fingerabdrücke bieten ...
Breaking Biology News(10 mins):Automatic Identification System Market by Class, by Platform, by Application and by Geography - Global Forecasts & Analysis to 2014 - 2020 2Body-Worn Temperature Sensors Market - Global Industry Analysis 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 2QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 3QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 4QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 5QIAGEN bringt in den USA neue Kits für die forensische DNA-Analyse auf den Markt 6
... black, brittle and freeze-dried (just like the ice cream ... Designed by Northwestern University chemists, it can remove mercury ... and, perhaps most impressive of all, is a more ... sulfur out of crude oil. Hydrodesulfurization might be ...
... have broken the stubborn impasse that has frustrated the ... approach that bypasses the usual path followed by vaccine ... that block infection, the scientists protected monkeys from infection ... virus, or SIVthat causes AIDS in rhesus monkeys. ...
... professor of medicine, physiology and biophysics at the Boston ... of vitamin D and its role in disease prevention, ... Health Research. The prize was presented at a ... Linus Pauling Institute at Oregon State University. It recognizes ...
Cached Biology News:One sponge-like material, three different applications 2One sponge-like material, three different applications 3Novel vaccine approach offers hope in fight against HIV 2Vitamin D expert receives Linus Pauling Prize for Health Research 2
(Date:6/30/2015)... ... June 30, 2015 , ... Students and faculty from ... first half of “Integrative Biotechnology,” an applied biotechnology course team-taught by faculty members ... course combines students from both universities and is taught on both continents. , ...
(Date:6/30/2015)... , June 30, 2015  NASA astronaut Kjell ... next month on his first mission to the International ... from 8 to 9 a.m. EDT Tuesday, July 7. ... in Star City, Russia . The interviews ... NASA Television highlighting his mission training. To schedule ...
(Date:6/30/2015)... ... 30, 2015 , ... uBiome and OpenBiome Partner for Microbiome ... fecal microbiota transplantation in C. difficile patients. , SAN FRANCISCO, uBiome and OpenBiome ... microbiota transplantation (FMT) as a treatment for Clostridium difficile infections (C. diff). , ...
(Date:6/30/2015)... ... June 30, 2015 , ... The maximum number of shares ... outstanding common shares (including shares of unvested restricted stock). On June 29, 2015, the ... price of Cryo-Cell’s shares reported on the OTCBB was $2.29 per share. , The ...
Breaking Biology Technology:Rivier University and Beijing City University Academic and Cultural Exchanges Begin 2NASA Astronaut Preps for First Space Station Mission, Available for Media Interviews 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 2uBiome and OpenBiome Partner for Microbiome Study in FMT Patients 3Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 2Cryo-Cell Commences Tender Offer to Purchase its Common Stock, Up to 750,000 Shares at $3.25 per Share 3
... Compendia Bioscience, Inc.,today announced the release ... a high-value product extension of Oncomine,Research Edition ... Edition includes custom gene filters, integration with ... Oncomine Concepts Map,including the ability to upload ...
... Oct. 16 DURECT Corporation,(Nasdaq: DRRX ) announced ... in,New York on October 17, 2007 at 12:00 p.m. ... begin at 12:30 p.m. Eastern Time and will,be available ... "Investor Relations". If you are unable to participate during ...
... - Isis will own 18 percent of Altair and will ... royalties on antisense drugs developed by ... ISIS 369645 for asthma, CARLSBAD, Calif. and SAN FRANCISCO, ... Thomas, McNerney & Partners,LLC, announced today that Altair Therapeutics Inc., ...
Cached Biology Technology:Compendia Bioscience Announces the Release and Availability of Oncomine(TM) Research Premium Edition 2Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 2Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 3Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 4Isis Pharmaceuticals and Thomas, McNerney & Partners Announce That the Newly Formed Altair Therapeutics Will Develop Antisense Drugs for Respiratory Conditions 5